| Literature DB >> 31296510 |
Jae Hyuk Choi1, Donghoon Han1, Si-Hyuck Kang2, Chang-Hwan Yoon2, Jung Rae Cho3, Dohern Kym4.
Abstract
OBJECTIVES: To date, no research has investigated the association between cardiac complication and electrical injury; hence, we aimed to assess the consequences and relating factors of cardiac complications from electrical injuries in South Korea.Entities:
Keywords: cardiac complications; electrical injuries; korea; prognosis; retrospective study; single centre
Year: 2019 PMID: 31296510 PMCID: PMC6624029 DOI: 10.1136/bmjopen-2018-028741
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Study flowchart. PCI, percutaneous coronary intervention.
Baseline characteristics
| Characteristics | Cardiac injury, N=107 | Control, N=614 |
| Age | 45.0±11.1 | 42.9±10.3 |
| Men, n (%) | 103 (96.3) | 599 (97.6) |
| Body weight (kg) | 69.6±9.1 kg | 69.3±10.6 |
| Height (cm) | 172±6.4 | 171±6.1 |
| BMI (kg/m2) | 23.5±2.7 | 23.7±3.1 |
| Smoking, n (%) | ||
| Never smoking | 58 (54.2) | 305 (49.7) |
| Smoking | 49 (45.8) | 309 (50.3) |
| HTN, n (%) | 12 (11.2) | 61 (9.9) |
| CAD, n (%) | 1 (0.9) | 4 (0.7) |
| DM, n (%) | 6 (5.6) | 24 (3.9) |
| CKD or ESRD, n (%) | 0 (0) | 1 (0.2) |
| Aspirin, n (%) | 1 (0.9) | 14 (2.3) |
| ACEi or ARB, n (%) | 6 (5.6) | 37 (6.0) |
| B-blocker, n (%) | 0 (0) | 11 (1.8) |
| Statin, n (%) | 0 (0) | 11 (1.8) |
| Metformin, n (%) | 4 (3.78) | 13 (2.1) |
ACEi, angiotensin-converting enzyme inhibitors; ARBs, angiotensin receptor blockers; BMI, body mass index; CAD, coronary artery disease; CKD, chronic kidney disease; DM, diabetes mellitus; ESRD, end-stage renal disease; HTN, hypertension.
Comparison of burn and admission characteristics between the cardiac complication and control groups
| Variables | Cardiac complication | Control | |
| High voltage, n (%) | 87 (81.3) | 426 (69.4) | 0.12 |
| ICU admission, n (%) | 80 (74.8) | 285 (46.4) | <0.01 |
| TBSA percentage | 24.4±19.3 | 20.2±18.0 | <0.01 |
| Severity*, n (%) | |||
| Minor | 35 (32.7) | 238 (38.8) | <0.01 |
| Moderate | 21 (19.6) | 127 (20.7) | <0.01 |
| Severe | 51 (47.7) | 249 (40.6) | <0.01 |
| Burn grade, n (%) | |||
| 2 | 8 (7.5) | 126 (20.5) | <0.01 |
| 3 | 90 (84.1) | 416 (67.8) | <0.01 |
| 4 | 9 (8.4) | 72 (11.7) | <0.01 |
| Admission duration (days) | 75.0±45.3 | 56.6±48.0 | <0.01 |
| ICU duration (days) | 19.3±24.1 | 10.4±15.5 | <0.01 |
| Amputation, n (%) | 19 (17.8) | 61 (9.9) | 0.04 |
| Escharotomy, n (%) | 33 (30.8) | 93 (15.1) | <0.01 |
| Fasciotomy, n (%) | 6 (5.6) | 30 (4.9) | 0.75 |
| Skin graft, n (%) | 87 (81.3) | 447 (72.8) | 0.03 |
| Total Op count, n (%) | |||
| 1 | 24 (22.4) | 174 (28.3) | 0.58 |
| 2 | 20 (18.7) | 118 (19.2) | 0.89 |
| 3 | 16 (15.0) | 76 (12.4) | 0.78 |
| ≥4 | 34 (31.8) | 111 (18.1) | 0.28 |
*Severity adapted American Burn Association: hospital and prehospital resources for optimal care of patients with burn injury: guidelines for development and operation of burn centres.29
ICU, intensive care unit; Op, operation; TBSA, total body surface area.
Figure 2Group-wise admission characteristics. (A) Admission duration for the cardiac complication and control groups. (B) ICU duration for the cardiac complication and control groups. (C) Kaplan-Meier graph for the cardiac complication and control groups. ICU, intensive care unit.
Figure 3Association among patients’ characteristics, injury characteristics and cardiac complications. BMI, body mass index; DM, diabetes mellitus; TBSA, total body surface area.